Efficacy of focal high-dose-rate brachytherapy in the treatment of patients diagnosed with low or favourable intermediate-risk prostate cancer—a protocol for a …
J Jonušas, A Patasius, M Trakymas, J Venius… - BMJ open, 2023 - bmjopen.bmj.com
Introduction Prostate cancer (PCa) is men's second most predominant cancer worldwide.
Because the prostate-specific antigen test is used in diagnostics, PCa is more often …
Because the prostate-specific antigen test is used in diagnostics, PCa is more often …
A novel nomogram to identify candidates for focal therapy among patients with localized prostate cancer diagnosed via magnetic resonance imaging–targeted and …
G Mjaess, A Peltier, JB Roche, E Lievore… - European Urology …, 2023 - Elsevier
Background Suitable selection criteria for focal therapy (FT) are crucial to achieve success in
localized prostate cancer (PCa). Objective To develop a multivariable model that better …
localized prostate cancer (PCa). Objective To develop a multivariable model that better …
[HTML][HTML] Protocol: Efficacy of focal high-dose-rate brachytherapy in the treatment of patients diagnosed with low or favourable intermediate-risk prostate cancer—a …
J Jonušas, A Patasius, M Trakymas, J Venius… - BMJ Open, 2023 - ncbi.nlm.nih.gov
ABSTRACT Introduction Prostate cancer (PCa) is men's second most predominant cancer
worldwide. Because the prostatespecific antigen test is used in diagnostics, PCa is more …
worldwide. Because the prostatespecific antigen test is used in diagnostics, PCa is more …
Stereotactic focal radiotherapy as an alternative treatment for low-risk prostate cancer: Results of a single-arm monocenter Phase-II trial
PV Nguyen, B Donneaux, C Louis, Z Bodgal… - Frontiers in …, 2023 - frontiersin.org
Introduction Since radical treatments in low risk prostate cancer do not improve overall
survival in comparison to active surveillance, preserving quality of life (QOL) remains the key …
survival in comparison to active surveillance, preserving quality of life (QOL) remains the key …
Résultats oncologiques et fonctionnels du traitement focal du cancer de prostate localisé par HIFU
C Debard, G Margue, C Klein, A Rompré-Brodeur… - Progrès en Urologie, 2023 - Elsevier
Résumé Introduction Depuis quelques années, l'amélioration du diagnostic du cancer de
prostate permet le développement de la thérapie focale, afin de diminuer la morbidité des …
prostate permet le développement de la thérapie focale, afin de diminuer la morbidité des …
The proportion of potential candidates for focal therapy in localized prostate cancer in a real-life cohort and their final pathologic results
D Azoulai, J Boustany, M Peyromaure… - Progrès en Urologie, 2022 - Elsevier
Objectives To determine the proportion of patients who would have been eligible for focal
therapy (FT) in a population of patients who underwent prostatectomies; additionally, to …
therapy (FT) in a population of patients who underwent prostatectomies; additionally, to …